AmacaThera Named Life Sciences Ontario Emerging Company of the Year
18.03.2026 - 10:16:40 | prnewswire.co.uk
Recognition of AmacaThera's leadership and landmark agreement with Pacira BioSciences for its long?acting, opioid?sparing anesthetic in post?operative pain managementProgressing AMT-143 to Phase 2 clinical development in 2026View original content:https://www.prnewswire.co.uk/news-releases/amacathera-named-life-sciences-ontario-emerging-company-of-the-year-302684232.html
en | boerse | 68774909 |
